ALS Limited has delivered record full-year results with underlying net profit after tax of $381.2 million, representing growth of 25.8% year-on-year. This earnings expansion significantly outpaced the 10.7% revenue growth to $3.32 billion, demonstrating substantial operational leverage and the quality of the earnings improvement. The result reflects a cyclical upturn in mineral exploration activity within the Commodities segment, favorable foreign exchange impacts in the first half, and lower interest costs following the company’s May 2025 equity raise.
The profit growth acceleration stems primarily from ALS’s Minerals segment, where margins expanded 167 basis points to 33.0% through consistent sample volume growth and positive pricing evolution in the second half. Underlying EBIT margin improved 129 basis points overall to 18.0%, with Commodities delivering strong growth and Life Sciences contributing a solid 55 basis point margin improvement despite mixed revenue conditions. This margin profile suggests the business is capturing meaningful operating leverage as volumes increase, a positive indicator for earnings trajectory during cyclical upswings in mineral exploration.
The balance sheet position has strengthened materially, with financial leverage declining to 1.5 times net debt to EBITDA, below management’s targeted range of 1.7 to 2.3 times. Free cash flow generation of $674.1 million, combined with the earlier equity raise, has repositioned ALS with more than $580 million in available liquidity. The company is returning capital to shareholders through a final dividend of 23.1 cents per share at a 57% payout ratio, while maintaining firepower to fund four recently announced hub laboratory projects that remain on track and within budget.
The Environmental segment presented a counterweight to the positive momentum, experiencing softer trading conditions in the second half. Challenges included internal quality and cost factors now under remediation, alongside external headwinds from weaker market conditions and project deferrals linked to the US government shutdown. Despite these pressures, both APAC and EMEA regions in the Environmental division delivered mid-single digit revenue growth, suggesting the weakness is geographically concentrated rather than systemic.
Investors should monitor the trajectory of the hub laboratory buildouts, which could drive meaningful future growth once operational, along with the sustainability of Commodities margin expansion as mineral exploration activity continues. The Environmental segment’s remediation efforts and the potential for improved conditions in the US market will be material to earnings quality. This announcement is price sensitive and has been flagged as material by the ASX.
View the full ASX announcement (PDF)
About ALS Limited (ASX: ALQ)
ALS Limited is a global leader in laboratory testing, inspection, certification, and verification services, operating from approximately 350 sites across 65 countries. The company operates two main divisions: Commodities, which provides assaying and metallurgical services for the mining sector, and Life Sciences, which offers analytical testing for environmental, food, pharmaceutical, and consumer products markets. Headquartered in Brisbane, Australia, ALS serves major clients across Africa, Asia Pacific, Europe, the Middle East, North Africa, and the United States.
If you would like to discuss this announcement or how it might affect your portfolio, request a callback or call us on 1300 889 603.
